Haemonetics

Yahoo Finance • 2 days ago

Haemonetics Q4 Earnings Call Highlights

Haemonetics logo Haemonetics (NYSE:HAE) reported fiscal fourth-quarter revenue of $346 million, up 5% on a reported basis and 9% organically excluding CSL, as strength in its Plasma and Blood Management Technologies businesses offset cont... Full story

Yahoo Finance • 21 days ago

Riverwater Sustainable Value Strategy Awaits Haemonetics Corporation’s (HAE) Market Validation

Riverwater Partners, an investment management company, released its “Sustainable Value Strategy” Q1 2026 investor letter. A copy of the letter can be downloaded here. In Q1 2026, the Riverwater Sustainable Value Strategy underperformed the... Full story

Yahoo Finance • last month

Is It Time To Reassess Haemonetics (HAE) After Prolonged Share Price Weakness

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. If you are wondering whether Haemonetics at around US$56.36 is starting to look attractively priced, the recent share... Full story

Yahoo Finance • 2 months ago

Does Haemonetics' (HAE) Hospital Rebound and NexSys Expansion Reframe Its Competitive Positioning?

In recent months, Haemonetics has reported a recovery in its Hospital division, supported by broader adoption of its FDA-approved NexSys PCS system with Persona Technology and the completed transition away from older PCS2 devices. This ope... Full story

Yahoo Finance • 2 months ago

2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have seen decent returns lately as healthcare stocks were up 3.8% over the past six month... Full story

Yahoo Finance • 2 months ago

3 Reasons HAE is Risky and 1 Stock to Buy Instead

Haemonetics’s 21.4% return over the past six months has outpaced the S&P 500 by 15.6%, and its stock price has climbed to $65.64 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplati... Full story

Yahoo Finance • 3 months ago

Strong Competitive Position Drove Haemonetics Corporation’s (HAE) Earnings Growth

Aristotle Capital Boston, LLC, an investment advisor, released its fourth-quarter investor letter for “Small Cap Equity Fund”. A copy of the letter can be downloaded here. U.S. small-cap equities reported modest gains in the fourth quarter... Full story

Yahoo Finance • 3 months ago

Here are the major earnings before the open Thursday

Major earnings expected before the bell on Thursday include: * Bristol-Myers Squibb Company (BMY [https://seekingalpha.com/symbol/BMY]) * Shell plc (SHEL [https://seekingalpha.com/symbol/SHEL]) * Barrick Mining Corporation (B [https... Full story

Yahoo Finance • 5 months ago

Solventum is the top performing healthcare supplies stock YTD

[Monitors used during Cardiac Surgery] Arctic-Images/DigitalVision via Getty Images The S&P healthcare index (XLV [https://seekingalpha.com/symbol/XLV]) saw moderate gains in 2025, reaching a YTD increase of 12.2% by mid-December, though... Full story

Yahoo Finance • 5 months ago

Should Competitive Pressure In Vascular Closure Devices Prompt a Reassessment by Haemonetics (HAE) Investors?

Earlier this week, Needham downgraded Haemonetics from “Buy” to “Hold,” pointing to intensifying competition in vascular closure devices from Abbott and Cordis and warning that this could weigh on the company’s Interventional Technologies... Full story

Yahoo Finance • 5 months ago

Riverwater Partners Small Cap Strategy Sold Its Stake in Haemonetics Corporation (HAE) in Q3

Riverwater Partners, an investment management company, released its “Small Cap Strategy” Q3 2025 investor letter. A copy of the letter can be downloaded here. The Small Cap Core Strategy reported solid results for the quarter but did not k... Full story

Yahoo Finance • 6 months ago

Haemonetics Reaches Analyst Target Price

In recent trading, shares of Haemonetics Corp. (Symbol: HAE) have crossed above the average analyst 12-month target price of $80.40, changing hands for $80.63/share. When a stock reaches the target an analyst has set, the analyst logicall... Full story

Yahoo Finance • 6 months ago

A Look at Haemonetics’s (HAE) Valuation Following a 51% 30-Day Share Price Surge

Haemonetics (HAE) has seen a lift in its stock price over the past month, gaining more than 51%. This move stands out when compared to the company’s broader track record and recent financial performance. See our latest analysis for Haemon... Full story

Yahoo Finance • 6 months ago

SG Capital Dumps Nearly 732,000 Haemonetics Shares Worth $59.1 Million

Key Points SG Capital sold 731,892 shares of Haemonetics. The investment firm currently holds 175,000 shares. The position now represents 0.8% of AUM, which places it outside the fund's top five holdings.These 10 stocks could mint the nex... Full story

Yahoo Finance • 6 months ago

Stocks making the biggest moves midday: Brighthouse Financial, Duolingo, Datadog, Snap & more

Check out the companies making the biggest moves midday: Brighthouse Financial — The insurance company soared 26% on after it announced it would be bought by Aquarian Capital for $70 per share in cash, or around $4.1 billion. The deal is e... Full story

Yahoo Finance • 6 months ago

Haemonetics Non-GAAP EPS of $1.27 beats by $0.16, revenue of $327M beats by $15.51M

* Haemonetics press release [https://seekingalpha.com/pr/20296106-haemonetics-corporation-announces-second-quarter-fiscal-2026-financial-results-available-on] (HAE [https://seekingalpha.com/symbol/HAE]): Q2 Non-GAAP EPS of $1.27 beats by... Full story

Yahoo Finance • 6 months ago

Haemonetics Q2 2026 Earnings Preview

* Haemonetics (HAE [https://seekingalpha.com/symbol/HAE]) is scheduled to announce Q2 earnings results on Thursday, November 6th, before market open. The consensus EPS Estimate is $1.11 [https://seekingalpha.com/symbol/HAE/earnings/estim... Full story

Yahoo Finance • 6 months ago

Should You Hold Haemonetics Corporation (HAE)?

Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. small/mid-cap equities reported solid results in the t... Full story

Yahoo Finance • 7 months ago

Dentsply Sirona, Acadia Healthcare, and Haemonetics Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling... Full story

Yahoo Finance • 7 months ago

TomTom signs multi-year agreement to deliver traffic services to Hyundai AutoEver’s navigation for European vehicle lineup

Hyundai AutoEver (HAE) and TomTom expand their partnership to equip vehicles across Europe with TomTom technology. TomTom Real-Time Traffic and Speed Camera Service to enhance HMG drivers’ in-dash navigation experience. AMSTERDAM, Oct. 0... Full story